BCR and acute lymphoblastic leukemia: Likewise, the presence of well-characterized fusion proteins in leukemia, notably the BCR-ABL fusion in chronic myelogenous leukemia and acute lymphoid leukemia, enabled the demonstration that circulating T cells could recognize neo-epitopes created by the fusion (74).